BristolMyers Squibb Company Strategy, SWOT and Corporate Finance Report [Report Updated: 04082017] Prices from USD $175
BristolMyers Squibb Company Strategy, SWOT and Corporate Finance Report
Summary
BristolMyers Squibb Company Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Key Highlights
BristolMyers Squibb Company BMS or 'the company' is a global biopharmaceutical company. BMS was formed by the merger of Bristol Myers and Squibb Pharmaceuticals in 1989, a move which at the time created the world's second largest drug company. The company operates in the Americas, Europe, Japan, Asia, Australia, the Middle East and Africa. BMS is headquartered in New York City, New York.
Scope
Detailed information on BristolMyers Squibb Company required for business and competitor intelligence needs
A study of the major internal and external factors affecting BristolMyers Squibb Company in the form of a SWOT analysis
An indepth view of the business model of BristolMyers Squibb Company including a breakdown and examination of key business segments
Intelligence on BristolMyers Squibb Company's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about BristolMyers Squibb Company, such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of BristolMyers Squibb Company and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess BristolMyers Squibb Company as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on BristolMyers Squibb Company's business structure, strategy and prospects.
Original Article: BristolMyers Squibb Company Strategy, SWOT and Corporate Finance Report [Report Updated: 04082017] Prices from USD $175
